Skip to main content

For the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability.

FOR US HEALTHCARE PROFESSIONALS ONLY

Request a Rep Referral Form
Skip to main content
Referral Form

ROUTINE ILD TESTS

You can uncover helpful clues for PH in routine ILD tests2

Routine ILD tests PH watchouts

PFTs (DLCO)*

PH watchouts

  • Low DLCO (<40% predicted)2-6
  • Disproportionate decline in DLCO vs FVC2,3†

CT scan2,7-10

PH watchouts

  • RV enlargement (eg, RV:LV ratio >1)
  • PA enlargement (eg, PA >32 mm)
  • Flattening of the septum
  • Enlarged pulmonary arteries in the lung periphery

Exercise capacity

PH watchouts

  • Poor results during exercise testing2-4,11,12‡
  • Marked or worsening desaturation or dyspnea
  • Severely reduced or worsened distance, particularly with stable PFTs
  • Impaired heart rate recovery

Oxygen needs

PH watchouts

  • Any need for supplemental oxygen2

BNP and NT-proBNP

PH watchouts

  • Elevated or increasing levels of BNP or NT-proBNP13-15
    • Levels correlate to the severity of cardiac stress16
    • Levels increase before symptoms of severe PH and heart failure (eg, peripheral edema, weight gain) are present16

Take a closer look at routine ILD test results to detect PH earlier.2,4

When your patient with ILD is getting worse, don't assume it's due to ILD—it may be PH4

Questions to consider asking your patients:

Why do they need supplemental oxygen now?2

Why is there a need to increase their supplemental oxygen?2

Do they have other signs of PH, like DLCO >40%?3-6

Can you confirm your ILD patient doesn’t have PH?

Was there evidence of PA enlargement during their last CT scan?2

Might poor results during exercise testing be due to PH?2-4,11,12

Maintain a high degree of suspicion for PH.2

*Declining FVC and DLCO are both measures of ILD disease progression and severity. In ILD, the decline in DLCO is thought to be due to alveolar destruction and thickening/compression of pulmonary capillaries. PH can cause damage to the microvasculature, resulting in an additional decline in DLCO that does not always correlate with FVC impairment.2-4,17-20
CPFE is commonly associated with the combination of preserved lung volumes and extremely low DLCO and also carries a high risk for PH. WSPH recommends using an FVC/DLCO ratio >1.6 as a threshold for suspecting PH in patients with ILD.4,21
Based on studies using the 6MWT.2-4

6MWT=6-minute walk test; BNP=B-type natriuretic peptide; CPFE=combined pulmonary fibrosis and emphysema; CT=computed tomography; DLCO=diffusing capacity of the lung for carbon monoxide; FVC=forced vital capacity; ILD=interstitial lung disease; LV=left ventricle; NT-proBNP=N-terminal pro–B-type natriuretic peptide; PA=pulmonary artery; PFT=pulmonary function test; PH=pulmonary hypertension; RV=right ventricular/right ventricle; WSPH=World Symposium on Pulmonary Hypertension.